background image

Paid Clinical Trials Iowa

Discover 693 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
FeaturedActive & Responsive

The Heartland Study

for
Pregnancy Related, Pregnancy Complications, Birth Defect,
Location: 3 recruiting locations
Sponsor: Heartland Health Research Alliance

Sex: Female

Age: 18+

Code: NCT05492708

Recruiting
Active & Responsive

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: 13 recruiting locations
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting
Active & Responsive

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

for
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor,
Location: 13 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12+

Code: NCT04924075

Phase2, Recruiting
Active & Responsive

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: 40 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting
Active & Responsive

Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study

for
Rotator Cuff Tears
Location: 3 recruiting locations
Sponsor: University of Michigan

Sex: All

Age: 40 - 70+

Code: NCT04831164

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

for
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis
Location: 15 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 12+

Code: NCT05503264

Phase3, Recruiting
Active & Responsive

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

for
Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1,
Location: 1 recruiting location
Sponsor: University of Iowa

Sex: All

Age: 18+

Code: NCT06395402

Phase2, Recruiting
Active & Responsive

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: 11 recruiting locations
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase1, Recruiting
Active & Responsive

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma

for
Multiple Myeloma
Location: 21 recruiting locations
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT04133636

Phase2, Recruiting
Active & Responsive

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: 18 recruiting locations
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04065399

Phase1, Phase2, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa